4basebio AG

WKN: A2YN80
ISIN: DE000A2YN801
Land: Deutschland

Nachricht vom 08.07.2020 | 18:05

4basebio AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

4basebio AG
08.07.2020 / 18:05
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Notification of Major Holdings

1. Details of issuer

Name:	4basebio AG
Street:	Waldhofer Str. 102
Postal code:	69123
City:	Heidelberg Germany
Legal Entity Identifier (LEI):	391200H5BDEVHMOV3U10

2. Reason for notification

X	Acquisition/disposal of shares with voting rights
	Acquisition/disposal of instruments
	Change of breakdown of voting rights
	Other reason:

3. Details of person subject to the notification obligation

Natural person (first name, surname): Joan V. Fernandez
Date of birth: 08 Jun 1965

4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.

Fernandez Family Trust

5. Date on which threshold was crossed or reached:

01 Jul 2020

6. Total positions

	% of voting rights attached to shares (total of 7.a.)	% of voting rights through instruments (total of 7.b.1 + 7.b.2)	Total of both in % (7.a. + 7.b.)	Total number of voting rights pursuant to Sec. 41 WpHG
New	4.997 %	0 %	4.997 %	48,525,915
Previous notification	7.10 %	0 %	7.10 %	/

7. Details on total positions
a. Voting rights attached to shares (Sec. 33, 34 WpHG)

ISIN	Absolute		In %
	Direct (Sec. 33 WpHG)	Indirect (Sec. 34 WpHG)	Direct (Sec. 33 WpHG)	Indirect (Sec. 34 WpHG)
DE000A2YN801		2,424,921	%	4.997 %
Total	2,424,921		4.997 %

b.1. Instruments according to Sec. 38 (1) no. 1 WpHG

Type of instrument	Expiration or maturity date	Exercise or conversion period	Voting rights absolute	Voting rights in %
			0	0.00 %
		Total	0	0.00 %

b.2. Instruments according to Sec. 38 (1) no. 2 WpHG

Type of instrument	Expiration or maturity date	Exercise or conversion period	Cash or physical settlement	Voting rights absolute	Voting rights in %
				0	0.00 %
			Total	0	0.00 %

8. Information in relation to the person subject to the notification obligation

	Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).
X	Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name	% of voting rights (if at least 3% or more)	% of voting rights through instruments (if at least 5% or more)	Total of both (if at least 5% or more)
Joan V. Fernandez, as one of the two joint trustees of the Fernandez Family Trust	%	%	%
Fernandez Family Trust	4.997 %	%	4.997 %

9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)

Date of general meeting:
Holding total positions after general meeting (6.) after annual general meeting:

Proportion of voting rights	Proportion of instruments	Total of both
%	%	%

10. Other explanatory remarks:

Date

06 Jul 2020

08.07.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language:	English
Company:	4basebio AG
	Waldhofer Str. 102
	69123 Heidelberg
	Germany
Internet:	www.4basebio.com


End of News	DGAP News Service

Kurschart

Kursdetails anzeigen

Interaktiv

Bildmaterial

weiteres Bildmaterial

Weblinks

weitere Links

DGAP-Watchlist

zur Registrierung

Übersicht Indizes

weitere Indizes

Weitere News

weitere News anzeigen

GBC-Fokusbox

Anleihe der German Real Estate Capital S.A. stark überdurchschnittlich attraktiv

Die Anleihe der German Real Estate Capital S.A. weist aktuell eine Effektivverzinsung von ca. 14 % auf. Da es sich hier quasi um eine Immobilien-Anleihe handelt, ist das Anleiherisiko überschaubar. Insgesamt verfügt die German Real Estate-Gruppe über 6 Objekte, 24 Bestands- und 22 Handelsobjekte, womit eine Kombination aus stetigen Einnahmen und attraktiven Entwicklerrenditen erreicht wird. Wir stufen die Anleihe als stark überdurchschnittlich attraktiv ein.

Zur Studie